[Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group]

Hautarzt. 1998 Mar;49(3):167-9. doi: 10.1007/s001050050722.
[Article in German]
No abstract available

MeSH terms

  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Melanoma / mortality
  • Melanoma / pathology
  • Melanoma / therapy*
  • Multicenter Studies as Topic
  • Neoplasm Staging
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Skin Neoplasms / mortality
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*
  • Survival Rate

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins